MAHLI MICHAEL: Open Payments
NPI 1194730663 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 69 payments from 11 companies in 2025. Trend: 2023 $764 · 2024 $1,161 · 2025 $1,360
Food & beverage: $1,360
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $331 |
| UCB, Inc. | 14 | $259 |
| Novartis Pharmaceuticals Corporation | 10 | $258 |
| ABBVIE INC. | 17 | $194 |
| Amgen Inc. | 10 | $164 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| PFIZER INC. | 1 | $30 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Bimzelx, COSENTYX, SAPHNELO, RINVOQ, OTEZLA, SKYRIZI, BENLYSTA, KRYSTEXXA.
Industry payments across NM — which companies pay providers there.
